Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025)

Enovis (ENOV) has 6 years of Asset Writedowns and Impairment data on file, last reported at $501.3 million in Q4 2025.

• On a quarterly basis, Asset Writedowns and Impairment fell 22.25% year-over-year to $501.3 million in Q4 2025; TTM through Dec 2025 was $1.7 billion, a 160.57% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 61.42% from the prior year.
• Asset Writedowns and Impairment for Q4 2025 stood at $501.3 million, down from $548.4 million in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for ENOV reached as high as $644.8 million in Q4 2024 and fell as low as -$67.8 million in Q2 2024.
• Historically, Asset Writedowns and Impairment has averaged $242.9 million across 3 years, with a median of $73.4 million in 2024.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 41.19% in 2024 and fell as far as 30.5% in 2024.
• Year by year, Asset Writedowns and Impairment stood at -$52.0 million in 2023, then soared by 1340.12% to $644.8 million in 2024, then declined by 22.25% to $501.3 million in 2025.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $501.3 million in Q4 2025, $548.4 million in Q4 2025, and $644.8 million in Q4 2024.